The Immune Signalling Pair combines Thymosin Alpha-1 with LL-37, covering thymic and host defence mechanisms in innate and adaptive immune cell models. The two act through separate pathways, which is why they are supplied together.
- Thymosin Alpha-1 10mg vial, a 28 amino acid thymic peptide
- LL-37 5mg vial, the 37 amino acid human cathelicidin peptide
Immune Signalling Pair research applications
- NF-kB and interferon-stimulated response element reporter assays in HEK293 lines transfected with TLR2 or TLR9, the Thymosin Alpha-1 readout
- Broth microdilution and SYTOX Green uptake as membrane permeabilisation readouts, the LL-37 arm
- FPR2 calcium flux and transwell chemotaxis in differentiated HL-60 cells, with antagonist controls
Research profiles: Thymosin Alpha-1 and LL-37
What is tested in this pair
This pair contains two products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Thymosin Alpha-1 | 99.76% | Janoshik Analytical | 12 Jan 2026 | View |
| LL-37 | 99.85% | Janoshik Analytical | 18 Mar 2026 | View |







